<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148977</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201602508</org_study_id>
    <nct_id>NCT03148977</nct_id>
  </id_info>
  <brief_title>Evaluating MMPs in Burns</brief_title>
  <official_title>Evaluating a Point-of-Care, Quantitative Matrix Metalloproteinase Assay as a Predictor of Successful Graft Take in Patients Undergoing Cutaneous Auto Grafting for Acute Burn Injury- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether our chemical assay can be used to&#xD;
      reliably predict graft take or failure in patients undergoing autologous skin grafting for&#xD;
      treatment of acute burn injury.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational pilot study of patients treated at UF Health Shands Burn Center&#xD;
      adult service. This is a study to determine the predictive value of quantifying&#xD;
      concentrations of specific MMPs. Coupling this with a specialized collection sample&#xD;
      collection system and a calibrated fluorimetry allows for the rapid assessment of MMP&#xD;
      concentrations. This assay has been validated as a predictor of failed wound healing in a&#xD;
      published clinical study involving chronic open wounds.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    IRB expired&#xD;
  </why_stopped>
  <start_date type="Actual">June 9, 2017</start_date>
  <completion_date type="Actual">December 8, 2020</completion_date>
  <primary_completion_date type="Actual">December 8, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictability of graft take</measure>
    <time_frame>2 years</time_frame>
    <description>Determine whether chemical assay can be used to reliably predict graft take or failure in patients undergoing autologous skin grafting for treatment of acute burn injury.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound healing</measure>
    <time_frame>2 years</time_frame>
    <description>Assess the predictive value of serial MMP assays in identifying wounds transitioning from likely-to-fail to likely-to-succeed</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8</enrollment>
  <condition>Burns</condition>
  <condition>Thermal Burn</condition>
  <condition>Thermal Injury</condition>
  <arm_group>
    <arm_group_label>Patients admitted to the burn center</arm_group_label>
    <description>Patients admitted to the Burn Service with acute burn injuries requiring at least one surgical excision and grafting operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Graft</intervention_name>
    <description>Autogenous skin grafting is the only definitive treatment for the full thickness burn injuries, and thus represents the centerpiece of modern burn care.</description>
    <arm_group_label>Patients admitted to the burn center</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Acute burn wound exudate Acute burn wound tissue&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult burn patients admitted&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Admitted with acute burns injuries (flame, contact or scald) requiring at least one&#xD;
             surgical excision and grafting operation will be considered for inclusion&#xD;
&#xD;
          -  Burn injury less than one week old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Electrical, chemical or cold-induced burn injury&#xD;
&#xD;
          -  Total body surface area burn &gt;50 %&#xD;
&#xD;
          -  Pre injury diagnosis of chronic renal insufficiency, liver failure, refusal to accept&#xD;
             blood transfusion or withdrawal of care within three days of admission will also be&#xD;
             exclusion criteria&#xD;
&#xD;
          -  Patients not expected to survive&#xD;
&#xD;
          -  Patients presenting with re-injury to previously burned and treated areas.&#xD;
&#xD;
          -  Patients who present after receiving burn excision surgery out an outside facility for&#xD;
             the current acute injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>98 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua S. Carson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UF Health Cancer Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UF Health Shands at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Matrix Metalloproteinases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

